Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Amla Administration on Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion.

NCT03633630 is registered in ClinicalTrials.gov with University of Guadalajara as lead sponsor.

NCT NCT03633630
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03633630 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Amla Administration on Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion.
Lead sponsor
University of Guadalajara
Phase
Phase 2/3
Overall status
Completed
Start date
April 1, 2019
Completion date
March 30, 2022
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic syndrome